Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy
Crossref DOI link: https://doi.org/10.1007/s40258-017-0311-4
Published Online: 2017-02-14
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ruggeri, M.
Basile, M. https://orcid.org/0000-0002-1098-2648
Coretti, S.
Drago, C.
Cicchetti, A.
License valid from 2017-02-14
